The odds ratio (OR) analysis showed that rs5030789 polymorphism in RAD51 and rs1799796 polymorphism in XRCC3 are associated with susceptibility to prostate cancer (Table 4). This evidence concerns the gene RAD51 and prostate carcinoma.